Literature DB >> 8256851

Is the "preamyloid" of diffuse plaques in Alzheimer's disease really nonfibrillar?

C A Davies1, D M Mann.   

Abstract

Several papers have described an 'amorphous' component of the amyloid in diffuse plaques and it has been suggested that this is 'preamyloid,' which is not organized into fibrils. Because most of the studies have been performed on autopsy tissue it was the purpose of this study to compare the ultrastructure of diffuse amyloid deposits in well preserved Alzheimer's disease biopsy specimens with autopsy tissues from patients with Alzheimer's disease and Down's syndrome. A postembedding immunogold technique with anti-beta/A4 protein demonstrated gold particles exclusively on extracellular amyloid fibrils in both biopsy and autopsy brains. We have presented evidence that suggests the claim for the existence of an amorphous component within the beta/A4 protein-positive material is unconvincing.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8256851      PMCID: PMC1887266     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. An immunoelectron microscopic study.

Authors:  H Yamaguchi; T Yamazaki; C A Lemere; M P Frosch; D J Selkoe
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

2.  Immunohistochemical and immunoelectron microscopical characterization of cerebrovascular and senile plaque amyloid in aged dogs' brains.

Authors:  T Ishihara; T Gondo; M Takahashi; F Uchino; S Ikeda; D Allsop; K Imai
Journal:  Brain Res       Date:  1991-05-10       Impact factor: 3.252

3.  Diffusion artificats in 3,3'-diaminobenzidine cytochemistry.

Authors:  A B Novikoff; P M Novikoff; N Quintana; C Davis
Journal:  J Histochem Cytochem       Date:  1972-09       Impact factor: 2.479

4.  DAB cytochemistry: artifact problems in its current uses.

Authors:  A B Novikoff
Journal:  J Histochem Cytochem       Date:  1980-09       Impact factor: 2.479

5.  Ultrastructural localization of argyrophilic substances in diffuse plaques of Alzheimer-type dementia demonstrated by methenamine silver staining.

Authors:  T Yamazaki; H Yamaguchi; K Okamoto; S Hirai
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

6.  High-resolution electron microscopic analysis of the amyloid fibril in Alzheimer's disease.

Authors:  H K Narang
Journal:  J Neuropathol Exp Neurol       Date:  1980-11       Impact factor: 3.685

7.  Relationship between non-fibrillary amyloid precursors and cell processes in the cortical neuropil of Alzheimer patients.

Authors:  K H el Hachimi; L Verga; G Giaccone; F Tagliavini; B Frangione; O Bugiani; J F Foncin
Journal:  Neurosci Lett       Date:  1991-08-05       Impact factor: 3.046

8.  Ultrastructure of diffuse plaques in senile dementia of the Alzheimer type: comparison with primitive plaques.

Authors:  H Yamaguchi; Y Nakazato; M Shoji; M Takatama; S Hirai
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

9.  Alzheimer patients: preamyloid deposits are immunoreactive with antibodies to extracellular domains of the amyloid precursor protein.

Authors:  F Tagliavini; G Giaccone; L Verga; J Ghiso; B Frangione; O Bugiani
Journal:  Neurosci Lett       Date:  1991-07-08       Impact factor: 3.046

10.  Ultrastructural localization of glial fibrillary acidic protein in mouse cerebellum by immunoperoxidase labeling.

Authors:  M Schachner; E T Hedley-Whyte; D W Hsu; G Schoonmaker; A Bignami
Journal:  J Cell Biol       Date:  1977-10       Impact factor: 10.539

View more
  13 in total

Review 1.  Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease.

Authors:  J C Morris; J L Price
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

2.  Aβ Plaques.

Authors:  Lary C Walker
Journal:  Free Neuropathol       Date:  2020-10-30

3.  Diffuse senile plaques: amorphous or fibrous?

Authors:  O Bugiani; F Tagliavini; G Giaccone; L Verga; K el-Hachimi; J F Foncin; B Frangione
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

4.  Synaptic changes in Alzheimer's disease: increased amyloid-beta and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence.

Authors:  Karen Hoppens Gylys; Jeffrey A Fein; Fusheng Yang; Dorothy J Wiley; Carol A Miller; Gregory M Cole
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

5.  Amyloid beta-protein (Abeta) 1-40 but not Abeta1-42 contributes to the experimental formation of Alzheimer disease amyloid fibrils in rat brain.

Authors:  R W Shin; K Ogino; A Kondo; T C Saido; J Q Trojanowski; T Kitamoto; J Tateishi
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

6.  Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

Authors:  A Lorenzo; B A Yankner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

7.  Alzheimer's disease: A hypothesis on pathogenesis.

Authors:  D Harman
Journal:  J Am Aging Assoc       Date:  2000-07

8.  Aminopeptidase A contributes to biochemical, anatomical and cognitive defects in Alzheimer's disease (AD) mouse model and is increased at early stage in sporadic AD brain.

Authors:  Audrey Valverde; Julie Dunys; Thomas Lorivel; Delphine Debayle; Anne-Sophie Gay; Sandra Lacas-Gervais; Bernard P Roques; Mounia Chami; Frédéric Checler
Journal:  Acta Neuropathol       Date:  2021-04-21       Impact factor: 17.088

9.  Comparing amyloid-β plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer disease.

Authors:  Nelly Joseph-Mathurin; Namita Sinha; Aihong Zhou; Nigel J Cairns; Tammie L S Benzinger; Charles D Chen; Yan Li; Karl Friedrichsen; Austin McCullough; Erin E Franklin; Russ Hornbeck; Brian Gordon; Vijay Sharma; Carlos Cruchaga; Alison Goate; Celeste Karch; Eric McDade; Chengjie Xiong; Randall J Bateman; Bernardino Ghetti; John M Ringman; Jasmeer Chhatwal; Colin L Masters; Catriona McLean; Tammaryn Lashley; Yi Su; Robert Koeppe; Clifford Jack; William E Klunk; John C Morris; Richard J Perrin
Journal:  Acta Neuropathol       Date:  2021-07-28       Impact factor: 15.887

10.  A fibril-specific, conformation-dependent antibody recognizes a subset of Abeta plaques in Alzheimer disease, Down syndrome and Tg2576 transgenic mouse brain.

Authors:  Floyd Sarsoza; Tommy Saing; Rakez Kayed; Robert Dahlin; Malcolm Dick; Camille Broadwater-Hollifield; Scott Mobley; Ira Lott; Eric Doran; Daniel Gillen; Clifford Anderson-Bergman; David H Cribbs; Charles Glabe; Elizabeth Head
Journal:  Acta Neuropathol       Date:  2009-04-10       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.